PreciseDx

PreciseDx is the only cancer risk stratification company that provides patient-specific risk information through morphological feature analysis, enabling better and more personalized treatment and outcomes. Clinical teams can rely on PreciseDx for unparalleled insights and actionable intelligence to determine the optimal treatment plan for each patient. PreciseDx combines the power of artificial intelligence with its proprietary Morphology Feature Array™ to create disease-specific analyses that provide new pathological information, insights into each patient’s risk profile, and potential outcomes to assist in treatment decision-making.